DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
Datavault AI expanded its technology licensing relationship with DataMeds AI to cover commercial healthcare, healthspan, and wellness applications, moving beyond pharmaceutical distribution. Under the amended definitive agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMeds AI upon closing of the related business combination transactions.
Key figures
- Dvlt equity stake in meds
- 19.9%
- Healthcare data global share
- 30%
- Healthcare data annual growth
- 36%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.